A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers

Recruiting N/A Interventional Study
Cancer of the Prostate Anxiety
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
376 (estimated)
Sponsor
St. Mary's Research Center, Canada · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Men with prostate cancer and their family caregivers face many physical and emotional challenges from the cancer itself and its treatment(s), which often lead to high anxiety. The pandemic has highlighted the importance of protecting our physical and mental health, and the complex responsibilities that caregivers have in supporting their loved ones. To improve the health of men with prostate cance…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Patient inclusion criteria: Prostate cancer diagnosis; Treatment for prostate cancer (excluding active surveillance) scheduled to start or received within the past 2 years; Nominate a caregiver willing to participate; Report at least moderate anxiety (ESAS-r Anxiety 3+); Be able to read English or F…
Contacts

Sylvie Lambert, PhD

514-398-3685

sylvie.lambert@mcgill.ca

CONTACT

Margit Fuchs, PhD

514-396-2847

margit.fuchs@mcgill.ca

CONTACT